Phenylhydrazines
Medchemexpress LLC Fructosamine hydrochloride | 39002-30-7 | 96.9% | 215.63 g/mol | C6H14ClNO5 | 50 MG
Fructosamine hydrochloride is the hydrochloride salt of an amino monosaccharide provided as a research reagent. It is described as a metabolic intermediate and structural component relevant to cell membrane and cartilage studies, and has been reported to cause site-specific DNA strand breaks in the presence of Cu2+.
- Research-grade amino sugar hydrochloride reagent.
- CAS number 39002-30-7.
- Molecular formula C6H14ClNO5; molecular weight 215.63 g/mol.
- Purity 96.9% as provided by the manufacturer.
- Available in multiple sizes, including 50 mg packaging.
- Useful for biochemical and cellular research involving metabolic intermediates and structural studies.
- May induce DNA strand breaks in the presence of copper; follow appropriate safety procedures.
Medchemexpress LLC (+)-PD 128907 hydrochloride | 300576-59-4 | 99.5% | 285.77 | 25 MG
(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist. It functions as a biochemical reagent and can be utilized as a biological material or organic compound for life science research. It exhibits high selectivity for dopamine D3 receptors over D2 receptors.
- Potent and selective dopamine D3 receptor agonist.
- Acts on D2 and D3 dopamine receptors.
- Inhibits dialysate DA levels in D3 knockout mice.
- Displaces [3H]spiperone binding from dopamine D3 receptors.
- Involved in GPCR/G protein and neuronal signaling pathways.
Medchemexpress LLC CDK4/6-IN-15 (hydrochloride) | 99.0% | C21H28ClFN8S | 25 MG
CDK4/6-IN-15 hydrochloride is an orally active and selective CDK4/6 inhibitor. It is used for research purposes to study cancer cell growth, specifically by inhibiting cell proliferation and arresting the cell cycle at the G1 phase. This compound suppresses retinoblastoma tumor suppressor protein (Rb) phosphorylation and E2 factor (E2F)-regulated gene expression.
- Orally active and selective CDK4/6 inhibitor.
- Inhibits cancer cell growth by arresting the cell cycle at G1 phase.
- Suppresses retinoblastoma tumor suppressor protein (Rb) phosphorylation at S780.
- Triggers apoptosis in MV4-11 and MDA-MB-453 cells.
- Potently inhibits FLT3 and MYLK4.
eMolecules ChemScene (2-Methoxy-6-methylphenyl)boronic acid 250mg 632281936 CS-0146708 0 000 1567218-43-2 MFCD11043444 165 980 C8H11BO3
ChemScene (2-Methoxy-6-methylphenyl)boronic acid 250mg 632281936 CS-0146708 0 000 1567218-43-2 MFCD11043444 165 980 C8H11BO3
eMolecules 502496-26-6 | 2,6-Difluorophenylhydrazine hydrochloride | Oakwood Chemical | MFCD03094169 | 180.580 | C6H7ClF2N2 | 95.000 | Cl.NNc1c(F)cccc1F | 1g | 537716019
2,6-Difluorophenylhydrazine hydrochloride | Oakwood Chemical | 502496-26-6 | MFCD03094169 | 180.580 | C6H7ClF2N2 | 95.000 | Cl.NNc1c(F)cccc1F | 1g | 537716019
Medchemexpress LLC Lomefloxacin (hydrochloride) | 98079-52-8 | 100.0% | 10 G
Lomefloxacin hydrochloride is an orally active difluoroquinolone antibiotic that inhibits bacterial topoisomerase II, preventing DNA supercoiling and replication. It induces ROS production and apoptosis, exhibiting broad-spectrum bactericidal activity against Gram-positive and Gram-negative bacteria, and anticancer effects against melanoma.
- Inhibits bacterial topoisomerase II
- Prevents DNA supercoiling and replication
- Induces ROS production and apoptosis
- Broad-spectrum bactericidal activity against Gram-positive and Gram-negative bacteria
- Exhibits anticancer effects against melanoma
- Used in the study of systemic bacterial infections, skin, and melanoma